PRP versus PRF for the face and hair: what changes in the preparation

PRP and PRF are autologous blood-derived preparations, but the labels do not define one universal product. Centrifuge force and time, tube additives, platelet and leukocyte content, activation, final volume, and delivery method can all change what is being used.

The acronyms are only starting labels. Two clinics can both sell “PRP” yet produce preparations with different cellular content and final volumes; the same is true of PRF. A study result is relevant only when the diagnosis, processing method, delivery route, treatment schedule, and outcome resemble the protocol being offered. ¹²³

Preparation changes the material

For selected androgenetic alopecia populations, systematic reviews suggest PRP can improve hair-density outcomes, but protocols and study quality vary. Facial rejuvenation studies use different endpoints and combinations, so “regenerative” is not a standardized outcome.

PRP generally describes plasma concentrated to contain more platelets than baseline whole blood, often prepared with an anticoagulant so it remains injectable. PRF relies on clotting and a fibrin network; depending on timing and protocol, it may begin as a liquid and then form a matrix or be handled as a solid fibrin product. The cited PRF consensus specifies force, rotor design, timing, and distinct liquid or solid protocols, illustrating why the acronym does not establish one fixed composition. ⁴

Centrifuge speed alone is not enough to reproduce a protocol. Rotor radius determines how revolutions per minute translate into relative centrifugal force; the consensus recommends reporting and controlling force rather than copying an RPM number across centrifuges. ⁴ Tube material and additives, spins, draw volume, layer selected, time to use, activation, and final yield can all change the preparation. “More platelets” does not automatically mean a better clinical result.

Hair and facial uses are separate evidence questions

A trademarked kit or a higher platelet number does not by itself establish a better clinical result. PRF is not automatically newer, more natural, or longer lasting. The facial systematic review pooled heterogeneous PRP and PRF studies; it does not establish that PRF is categorically superior to PRP for a specific face or hair endpoint. ⁵

For androgenetic alopecia, the cited systematic review and meta-analysis found a signal that PRP can improve hair-density outcomes in selected populations. It also found protocol heterogeneity and limitations in the evidence base. That finding should not be extended to every cause of shedding. Scarring alopecia, alopecia areata, telogen effluvium, traction, nutritional or endocrine contributors, and medication-related shedding can require different evaluation and treatment.

Hair studies may measure hairs per square centimeter, hair diameter, global photographs, investigator scores, or patient satisfaction. Those endpoints are not interchangeable. Ask whether the clinic uses a defined scalp location, consistent hair length and styling, fixed camera distance, and the same counting method. A package that promises “thicker hair” without a baseline diagnosis or measurement cannot show whether the preparation helped.

Facial claims are more diffuse. “Rejuvenation” can refer to texture, fine lines, pigment, scar appearance, hydration, volume, or short-lived swelling. In the cited systematic review, thickness and elasticity had the strongest reported signals; wrinkle, texture, dyschromia, and especially hydration findings were less consistent. ⁵ Variable preparations, delivery routes, session counts, and scales prevent those pooled findings from becoming a promise that one local PRF recipe lasts longer than PRP.

Delivery route creates another intervention

Direct injection into scalp or facial tissue is different from spreading a preparation over skin after microneedling. FDA’s microneedling consumer information states that authorized microneedling devices are not approved for delivery of cosmetics, topical medicines, vitamin solutions, drugs, or blood products into the skin. A provider combining a device with PRP or PRF should identify the microneedling device, needle configuration and depth, intended use, and evidence for that combined protocol.

Clearance of a centrifuge, tube, or blood-processing component does not equal FDA approval of “PRP facial” or “PRF hair restoration” as a finished treatment claim. Ask which components are cleared for their stated function and which clinical use is being proposed. Avoid the shortcut that “from your own blood” creates blanket regulatory approval.

Material risks and response planning

Autologous origin reduces some product-compatibility questions but does not remove blood-draw, contamination, injection, pain, bruising, infection, scarring, or procedure-specific risks. Adding exosomes, drugs, vitamins, or other products creates a different intervention.

Autologous sourcing avoids some foreign-material questions, but it does not make the process sterile by definition. Venipuncture can cause bruising, fainting, or difficulty obtaining the required volume. Processing and transfer create contamination and labeling risks. Injection or microneedling can cause pain, bleeding, infection, inflammation, pigment change, scarring, or injury to local structures.

Ask how specimens remain linked to the correct patient, which disposable components are single-use, how the work area is controlled, and what happens if the tube, spin, clot timing, or final volume does not meet protocol. The record should name the preparation kit and tubes, centrifuge, processing parameters, additives, final volume, delivery method, treatment area, and operator.

Bundles need to be unpacked. Local anesthetic, calcium chloride or another activator, filler, minoxidil, microneedling, laser, exosomes, vitamins, or peptides each change the exposure. “PRF plus” is not evidence that PRF itself produced the outcome, and an added unapproved product cannot hide behind the autologous acronym.

Protocol questions worth asking

1. 1. What makes this preparation PRP or PRF? Request the tube, additives, spins, force, timing, collected layer, and final form instead of accepting the acronym alone.
2. 2. Which diagnosis is being treated? For hair, distinguish patterned loss from other causes; for face, name texture, scar, line, pigment, or volume as the endpoint.
3. 3. How closely does the cited study match this protocol? Compare population, processing, dose, delivery route, number of sessions, control group, and measured outcome.
4. 4. What exactly is added to the blood product? List anesthetics, activators, drugs, fillers, biologic products, or supplements and evaluate each component separately.
5. 5. Is a microneedling device being used as a delivery system? Ask whether that use follows the device's authorization and what evidence supports applying or introducing the preparation.
6. 6. What result ends the series? Set a hair-count, photograph, scar-scale, or other defined review point before buying open-ended maintenance visits.

Choose by indication and reproducibility

Compare a protocol, not an acronym. Ask for the tube manufacturer, anticoagulant or additive, centrifuge model, relative centrifugal force, spin time, final volume, intended platelet or fibrin characteristics, delivery depth, number of sessions, and outcome measure.

PRP has the more developed evidence base for selected androgenetic alopecia outcomes, but the average result from heterogeneous trials does not guarantee benefit from an unnamed local recipe. PRF may offer handling characteristics a clinician wants for a particular plan, yet its fibrin matrix and lack of anticoagulant do not establish superior clinical durability on their own.

The burden includes blood draw, preparation, discomfort control, injections or device passes, temporary redness or swelling, repeated sessions, photographs, and time before a meaningful outcome can be assessed. Compare that complete protocol with established alternatives for the diagnosed condition, including the option to investigate a cause of hair loss before an elective series.

A defensible choice can be summarized without the word “regenerative”: this preparation, delivered this way, for this diagnosed target, measured by this method after this number of sessions. If a clinic cannot complete that sentence, the PRP-versus-PRF label is doing more work than the evidence.